Bill > HB2557

This bill modifies Texas insurance law to expand requirements around prior authorization for prescription drugs treating chronic health conditions. The bill broadens the scope of an existing law by replacing language focused specifically on autoimmune diseases and blood disorders with a more comprehensive definition of "chronic health condition" that includes illnesses lasting at least one year which either require ongoing medical management or significantly limit a person's daily living activities. Under the new provision, health benefit plan issuers would be prohibited from requiring enrollees to obtain more than one prior authorization per year for prescription drugs treating chronic health conditions, which now explicitly includes autoimmune diseases, hemophilia, neurodegenerative diseases, and Von Willebrand disease. The changes will apply to health benefit plans delivered, issued, or renewed on or after January 1, 2026, with the bill itself taking effect on September 1, 2025. The bill aims to reduce administrative burdens for patients managing long-term health conditions by limiting the frequency of prior authorization requirements for necessary prescription medications.

Business and Industry

https://capitol.texas.gov/BillLookup/History.aspx?LegSess=89R&Bill=HB2557